Hyperfine | AI-Powered Portable MRI

Hyperfine, Inc. (Nasdaq: HYPR) is pioneering a revolutionary shift in medical technology with its groundbreaking Swoop® system. This portable, ultra-low-field, magnetic resonance brain imaging system has garnered accolades as the world’s first FDA-cleared device of its kind. Since its founding in 2014, Hyperfine's mission has been to bring MR brain imaging within reach, thereby transforming patient care on a global scale. The Swoop® system, which received initial U.S. Food and Drug Administration (FDA) clearance in 2020, fills a vital gap by enabling imaging at multiple points of care.

Operating in the Health Care sector and headquartered in the United States, the company recently secured a substantial $3.00M Grant investment on 18 May 2023. Notably, this funding round was backed by none other than the Bill & Melinda Gates Foundation, further cementing Hyperfine's position as a game-changer in the medtech space.

With its innovative Swoop® system, Hyperfine, Inc. is poised to make significant strides in providing accessible, clinically relevant diagnostic imaging and data solutions, ultimately reshaping the landscape of brain imaging and patient diagnostics across the globe.